About Us
Careers
Partner with us
Forgot password?
Sign in
Login
Login
Email
Password
Forgot your password?
Join VuMedi
Select specialty
Your main specialty
Adult & Family Medicine
Allergy, Asthma, Immunology
Anesthesiology
Cardiovascular
Dental
Dermatology
Emergency Medicine
Endocrinology
Gastroenterology & Hepatology
General Surgery
Hematology & Oncology
Infectious Disease
Medical Genetics
Nephrology
Neurology
Neurosurgery
Obstetrics/Gynecology
Ophthalmology
Oral Maxillofacial
Orthopaedics
Otolaryngology
Pathology
Pediatrics
Physical Medicine & Rehab
Plastic Surgery
Podiatry
Preventive Medicine
Psychiatry
Pulmonology
Radiation Oncology
Radiology
Rheumatology
Urology
First name
Last name
Email
Choose Password
Playback speed
0.5x
0.75x
1x (Normal)
1.25x
1.5x
1.75x
2x
10 seconds
K
Metastatic Upper-GI Malignancy: Case Presentation and Expert Panel Discussion
By
Integrity Continuing Education
FEATURING
Katherine Bever
,
Jonathan Hernandez
,
Samuel Klempner
By
Integrity Continuing Education
FEATURING
Katherine Bever
,
Jonathan Hernandez
,
Samuel Klempner
47 views
March 27, 2024
0 Comments
Login to view comments.
Click here to Login
Featured Video
10:25
Exelixis
Explore the mechanism of Action of a TKI in HCC
Feat.
W. Keiser
Featured Video
15:07
Exelixis
Safety and Efficacy Data of a TKI Monotherapy in HCC
Feat.
J. Mizrahi
Related Content
AUTOPLAY
ON
57:44
Vogl, NY
Vogl,NY on How to Ask Good Questions at Medical Meetings
Feat.
S. Vogl
10:22
Houston Methodist Hospital
mRNA Vaccine in Treatment of Pancreatic Cancer
Feat.
J. Gonzalez
27:37
ASCO GI 2023 Conference Coverage
ASCO GI 2023 Expert Panel Discussion: Practice-Changing Updates
Feat.
N. Uboha,
A. Turk,
K. Spencer,
M. Cecchini
27:04
Fengting Yan
Cancer Screening Molecular Tools
23:58
ASCO GI 2023 Conference Coverage
ASCO GI 2023 Key Studies
Feat.
R. Kim,
R. Mehta
06:47
UCSF School of Medicine
Tumor-Agnostic Efficacy & Safety of Selpercatinib in RET Fusion+…
Feat.
H. Kang
17:50
AdventHealth
Clinical Highlights From AACR 2024: Trials Evaluating Selected New T…
Feat.
G. Sonpavde
19:41
Balazs Halmos
How I Manage Immune Adverse Events in Solid Tumors
06:03
Total Health
2024 Updates on Targeted Approaches for GI Cancers and New Data in N…
Feat.
A. Grothey
03:50
UCLA Health
Perspectives on the Recent FDA Approval of NALIRIFOX in Frontline Me…
Feat.
Z. Wainberg
39:04
2023 Johns Hopkins Updates in Gastrointestinal Cancers
Localized Pancreatic Cancer Controversial Cases: Panel Discussion
Feat.
M. Katz,
A. De Jesus-Acosta,
N. Zaidi,
J. He,
A. Narang,
T. Bekaii-Saab
07:53
Total Health
Updates on Pancreatic Cancer - 2023 ASCO® Direct Philadelphia
Feat.
D. Lin
08:08
Integrity Continuing Education
Updates in Nonmetastatic Upper-GI Adenocarcinoma
Feat.
J. Hernandez
30:55
2023 Johns Hopkins Updates in Gastrointestinal Cancers
Medical Oncology Updates in Pancreas Cancer
Feat.
T. Bekaii-Saab
34:01
MedNews Week
Latest Treatment Strategies and Standard of Care for Pancreatic Canc…
Feat.
M. Pishvaian
29:25
Young Chae
Hyperprogression in Cancer Treated With Immunotherapy
06:28
Shubham Pant
FDA Approval of Liposomal Irinotecan/NALIRIFOX in 1L Metastatic Panc…
17:05
Insights from 2023 ESMO Annual Meeting
ESMO 2023 Insights: "A Multicenter, Randomized, Open-Label, Thr…
Feat.
A. Ohba
22:10
Yale Cancer Center
Pancreatic Cancer Updates From Yale Cancer Center
Feat.
J. Lacy
25:56
OncoAlert
Year in Review: Pancreatic Cancers
Feat.
M. Lewis
